AsymBio, a subsidiary of Asymchem, is committed to being a technology-driven CDMO with a global vision and best-in-class solutions for bioconjugates, antibodies, etc. We are capable of delivering bioconjugate IND projects within 13 months and BLA projects within 24 months. AsymBio is the innovative, reliable and client-centric CDMO partner driven for your success in the competitive pharmaceutical landscape.